Low-dose radiation for heart failure
Part of Heart & circulation clinical trials.
This trial tests whether very low doses of radiation can help people with chronic heart failure whose symptoms persist despite standard treatments. It aims to reduce inflammation in the heart and improve how well it pumps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have chronic systolic heart failure (your heart doesn't pump blood well) with symptoms like shortness of breath or tiredness, even when you're resting a bit.
- Your heart's pumping strength (ejection fraction) is less than 40%.
- Your symptoms continue despite taking the best heart failure medicines available.
- You agree to use birth control if you are a woman who could become pregnant.
- You have not had radiation therapy to your chest before, have not had a heart transplant, and do not have any metal implants that prevent an MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether remote monitoring of heart function can help manage heart failure. It may be an option if you have symptoms like shortness of breath or fatigue (NYHA class II or higher) and are between 18 and 90 years old.
This study tests a new radiation treatment for advanced heart failure. It aims to see if radiation can improve heart function and symptoms.
This trial tests if a low dose of radiation to the whole heart can help people with very advanced heart failure. It is for people who have severe symptoms despite maximum medications and are not candidates for a heart pump or transplant.
This trial tests if a low dose of radiation to the heart can help people with advanced heart failure feel better and improve heart function. It is for patients whose heart failure is stable but severe, and who are already on the best medications.
This trial looks at how radiation for lung, esophageal, or breast cancer affects the heart. It may help doctors reduce heart damage in future patients.
This trial tests a new way to plan radiation for cancers in the chest area (like lung, esophageal, or thymus cancers) that aims to protect the heart from high doses of radiation. It is for people who need daily radiation for at least three weeks and who are expected to live more than a year.
Hear when a new Heart Failure - NYHA II - IV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.